Log in

Allena Pharmaceuticals Stock Price, Forecast & Analysis (NASDAQ:ALNA)

$1.87
+0.20 (+11.98 %)
(As of 11/20/2019 03:21 AM ET)
Today's Range
$1.62
Now: $1.87
$1.90
50-Day Range
$1.62
MA: $4.13
$5.91
52-Week Range
$1.55
Now: $1.87
$10.66
Volume455,600 shs
Average Volume149,174 shs
Market Capitalization$43.88 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02
Allena Pharmaceuticals, Inc, a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States and internationally. The company's lead product candidate is reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ALNA
CUSIPN/A
Phone617-467-4577

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$2.38 per share

Profitability

Net Income$-35,650,000.00

Miscellaneous

Employees49
Market Cap$43.88 million
Next Earnings Date3/5/2020 (Estimated)
OptionableNot Optionable

Receive ALNA News and Ratings via Email

Sign-up to receive the latest news and ratings for ALNA and its competitors with MarketBeat's FREE daily newsletter.


Allena Pharmaceuticals (NASDAQ:ALNA) Frequently Asked Questions

What is Allena Pharmaceuticals' stock symbol?

Allena Pharmaceuticals trades on the NASDAQ under the ticker symbol "ALNA."

How were Allena Pharmaceuticals' earnings last quarter?

Allena Pharmaceuticals Inc (NASDAQ:ALNA) issued its earnings results on Wednesday, November, 13th. The company reported ($0.57) earnings per share for the quarter, missing the consensus estimate of ($0.49) by $0.08. View Allena Pharmaceuticals' Earnings History.

When is Allena Pharmaceuticals' next earnings date?

Allena Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Allena Pharmaceuticals.

What price target have analysts set for ALNA?

5 analysts have issued twelve-month price targets for Allena Pharmaceuticals' shares. Their forecasts range from $4.00 to $31.00. On average, they anticipate Allena Pharmaceuticals' stock price to reach $20.60 in the next year. This suggests a possible upside of 1,001.6% from the stock's current price. View Analyst Price Targets for Allena Pharmaceuticals.

What is the consensus analysts' recommendation for Allena Pharmaceuticals?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allena Pharmaceuticals in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Allena Pharmaceuticals.

Has Allena Pharmaceuticals been receiving favorable news coverage?

Media stories about ALNA stock have trended extremely negative this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Allena Pharmaceuticals earned a news sentiment score of -5.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Allena Pharmaceuticals.

Are investors shorting Allena Pharmaceuticals?

Allena Pharmaceuticals saw a increase in short interest in October. As of October 31st, there was short interest totalling 100,500 shares, an increase of 6.9% from the September 30th total of 94,000 shares. Based on an average trading volume of 262,500 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.8% of the shares of the stock are sold short. View Allena Pharmaceuticals' Current Options Chain.

Who are some of Allena Pharmaceuticals' key competitors?

What other stocks do shareholders of Allena Pharmaceuticals own?

Who are Allena Pharmaceuticals' key executives?

Allena Pharmaceuticals' management team includes the folowing people:
  • Dr. Alexey L. Margolin, Co-Founder & Chairman (Age 66)
  • Dr. Louis Brenner, Pres, CEO & Director (Age 49)
  • Mr. Edward J. Wholihan, CFO and VP of Fin. & Admin. (Age 59)
  • Mr. Robert Gallotto, Co-Founder & Strategic Adviser (Age 54)
  • Mr. Hugh Wight, Sr. VP of Technical Operations

When did Allena Pharmaceuticals IPO?

(ALNA) raised $80 million in an initial public offering on Thursday, November 2nd 2017. The company issued 5,300,000 shares at $14.00-$16.00 per share. Credit Suisse, Jefferies and Cowen served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Who are Allena Pharmaceuticals' major shareholders?

Allena Pharmaceuticals' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Wedbush Securities Inc. (0.11%). View Institutional Ownership Trends for Allena Pharmaceuticals.

Which institutional investors are buying Allena Pharmaceuticals stock?

ALNA stock was purchased by a variety of institutional investors in the last quarter, including Wedbush Securities Inc.. View Insider Buying and Selling for Allena Pharmaceuticals.

How do I buy shares of Allena Pharmaceuticals?

Shares of ALNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Allena Pharmaceuticals' stock price today?

One share of ALNA stock can currently be purchased for approximately $1.87.

How big of a company is Allena Pharmaceuticals?

Allena Pharmaceuticals has a market capitalization of $43.88 million. The company earns $-35,650,000.00 in net income (profit) each year or ($1.72) on an earnings per share basis. Allena Pharmaceuticals employs 49 workers across the globe.View Additional Information About Allena Pharmaceuticals.

What is Allena Pharmaceuticals' official website?

The official website for Allena Pharmaceuticals is http://www.allenapharma.com/.

How can I contact Allena Pharmaceuticals?

Allena Pharmaceuticals' mailing address is ONE NEWTON EXECUTIVE PARK SUITE 202, NEWTON MA, 02462. The company can be reached via phone at 617-467-4577.


MarketBeat Community Rating for Allena Pharmaceuticals (NASDAQ ALNA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  167 (Vote Outperform)
Underperform Votes:  165 (Vote Underperform)
Total Votes:  332
MarketBeat's community ratings are surveys of what our community members think about Allena Pharmaceuticals and other stocks. Vote "Outperform" if you believe ALNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Featured Article: What is the Quick Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel